References in periodicals archive ?
Cancer Breakthroughs 2020 will continue to work with the PC4C to further its reach toward onboarding key stakeholders in the cancer community to fight and win the war against cancer.
The PC4C, in its commitment to testing and vetting leading edge technologies through clinical trials, aligns with the Cancer Breakthroughs 2020 program's Quantitative Integrative Lifelong Trial (QUILT) which is designed to evaluate novel combinations of immunotherapies with the goal of achieving durable, long-lasting remission for patients with cancer.
Through PC4C the costs for the test will also be covered for non-Independence insured brain tumor patients through grant support of the research study.
In addition to initiating clinical research studies, PC4C institutions will work together to advance data-driven discovery through the rapid sharing and release of data to the entire research community through open science initiatives.
All patient-consented data for the PC4C will be accessible to the research community via Cavatica (cavatica.org), a newly launched biomedical data analysis and storage platform that for the first time will integrate adult and pediatric brain tumor data.
Acronyms browser ?
Full browser ?
- PCA pump
- PCA TX